9 Recruiting Trials

Clinical Trials for Asthma in New Jersey

9 clinical trials for Asthma are currently recruiting participants at study sites in New Jersey. Study-related care is provided at no cost.

Showing 9 of 9 recruiting Asthma trials in New Jersey

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
PHASE3 New Brunswick, New Jersey +4 sites NCT06979323
Recruiting
Individualizing Treatment for Asthma in Primary Care (Full Study)
PHASE4 Aurora, Colorado +4 sites NCT07052942
Recruiting

Asthma clinical trials in New Jersey: common questions

How many Asthma clinical trials are recruiting in New Jersey?
TrialFinder currently lists 9 recruiting Asthma clinical trials with study sites in New Jersey. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Asthma clinical trials located in New Jersey?
Study sites for the Asthma trials listed on this page include New Brunswick. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Asthma clinical trial in New Jersey?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Asthma trials in New Jersey also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Asthma clinical trial in New Jersey?
Each study sets its own criteria based on age, Asthma diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Asthma trials near you in New Jersey.

Get Matched — Free
No insurance required

Asthma trials evaluate biologic therapies, inhaler formulations, allergen immunotherapy, and environmental interventions for moderate-to-severe asthma and COPD overlap.

All Asthma trials →